Christophe Schilling, Ph.D.  |  CEO, co-founder

Christophe founded Genomatica in 1998. Since being named CEO in May 2009, he has led Genomatica to widespread recognition as a leader in industrial biotech, with a commercialized first process and plant and multiple leading partners. The company has earned awards for industry impact (recognized in ICIS Top40 Power Players five years in a row), engineering (Kirkpatrick), science (EPA Presidential Green Chemistry), industry leadership (voted #1 Hottest four years in a row by Biofuels Digest), and company culture (The Scientist as a Best Place to Work). Christophe is Chairman of Biocom, the largest advocate organization for California’s life sciences sector; serves on BIO’s Industrial & Environmental Section Governing Board; and has previously served on the World Economic Forum Global Agenda Council on Biotechnology. He is also a member of YPO, an international leadership organization for chief executives.

Christophe holds a Ph.D. in bioengineering from the University of California, San Diego. He received a B.S. in biomedical engineering from Duke University and was honored as a Distinguished Young Alumnus in 2010.

Follow Us

Sign up for Genomatica updates…

Data Collection Notice: In accordance with the California Consumer Privacy Act (CCPA), residents of California may obtain information about the categories of personal information that is collected and the business purpose(s) for which personal information is collected here: Privacy Statement for California Residents..

For additional information about our privacy practices (including information for E.U. residents about privacy rights under E.U. law), please also visit our Privacy Policy.